KEY FINDINGS
The global clinical trial management market is set to project a CAGR of 11.77% during the forecast period, 2021-2028. The growing number of clinical trials, research & development, rising chronic disease incidences, CTM software benefits, and research & development are significant growth drivers.
MARKET INSIGHTS
Clinical trial management systems include various components that comprise services, hardware, and software. It helps in maintaining the complex data obtained from clinical trials. Clinical trials are on the rise globally, attributed to technological advancements and the growing demand for advanced drugs with fewer side effects. The discovery of new treatments is propelled by rapid innovations in data management, biotechnology, and artificial intelligence. With every new drug, treatment, and device needing to undergo clinical trial, the volume of trials continues to rise.
Moreover, medicine is changing at a fast-paced pace. There is an increasing demand for services and software to manage the piling data from the rising clinical trials. Such factors are projected to drive market growth. However, the implantation costs, security concerns, and the lack of skilled healthcare professionals hinder the market growth.
REGIONAL INSIGHTS
The global clinical trial management market growth evaluation includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is estimated to harbor the largest revenue share. At the same time, Asia-Pacific is set to record the highest CAGR by 2028. The market prospects of Asia-Pacific are attributed to the increasing clinical trial management product awareness and dense population base.
COMPETITIVE INSIGHTS
The market has an increasing number of market players, along with a considerable scope of innovation. Bio-Optronics Inc, Medidata Solutions Inc, Arisglobal LLC, Bioclinica Inc, etc., are among the leading companies in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS - HEALTHCARE
3.2. MARKET SCOPE
3.3. KEY DRIVERS
3.3.1. OUTSOURCING OF CLINICAL TRIALS
3.3.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
3.3.3. AWARENESS REGARDING THE BENEFITS OF CTM SOFTWARE
3.3.4. INCIDENCES OF CHRONIC DISEASES
3.3.5. RESEARCH & DEVELOPMENT
3.4. KEY RESTRAINTS
3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
3.4.2. COST OF IMPLEMENTATION
3.4.3. SECURITY CONCERNS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. THREAT OF SUBSTITUTION
4.3.4. THREAT OF NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY END-USER
5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
5.2. CLINICAL RESEARCH ORGANIZATIONS
5.3. HEALTHCARE PROVIDERS
6. MARKET BY PRODUCT TYPE
6.1. ENTERPRISE-BASED CTM
6.2. SITE-BASED CTM
7. MARKET BY DEPLOYMENT MODEL
7.1. WEB-BASED DEPLOYMENT
7.2. ON-PREMISE DEPLOYMENT
7.3. CLOUD-BASED DEPLOYMENT
8. MARKET BY COMPONENT
8.1. SOFTWARE
8.2. HARDWARE
8.3. SERVICES
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.2. CANADA
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. KEY GROWTH ENABLERS
9.2.3. KEY CHALLENGES
9.2.4. KEY PLAYERS
9.2.5. COUNTRY ANALYSIS
9.2.5.1. UNITED KINGDOM
9.2.5.2. GERMANY
9.2.5.3. FRANCE
9.2.5.4. ITALY
9.2.5.5. RUSSIA
9.2.5.6. BELGIUM
9.2.5.7. POLAND
9.2.5.8. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. KEY GROWTH ENABLERS
9.3.3. KEY CHALLENGES
9.3.4. KEY PLAYERS
9.3.5. COUNTRY ANALYSIS
9.3.5.1. CHINA
9.3.5.2. JAPAN
9.3.5.3. INDIA
9.3.5.4. SOUTH KOREA
9.3.5.5. INDONESIA
9.3.5.6. THAILAND
9.3.5.7. VIETNAM
9.3.5.8. AUSTRALIA & NEW ZEALAND
9.3.5.9. REST OF ASIA-PACIFIC
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. KEY GROWTH ENABLERS
9.4.3. KEY CHALLENGES
9.4.4. KEY PLAYERS
9.4.5. REGION ANALYSIS
9.4.5.1. LATIN AMERICA
9.4.5.2. MIDDLE EAST AND AFRICA
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
10.2. COMPANY PROFILES
10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
10.2.2. ARISGLOBAL LLC
10.2.3. BIOCLINICA INC
10.2.4. BIO-OPTRONICS INC
10.2.5. IBM CORPORATION
10.2.6. MEDIDATA SOLUTIONS INC
10.2.7. MEDNET SOLUTIONS INC
10.2.8. ORACLE CORPORATION
10.2.9. PAREXEL INTERNATIONAL CORPORATION
10.2.10. VEEVA SYSTEMS INC
1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
2. ARISGLOBAL LLC
3. BIOCLINICA INC
4. BIO-OPTRONICS INC
5. IBM CORPORATION
6. MEDIDATA SOLUTIONS INC
7. MEDNET SOLUTIONS INC
8. ORACLE CORPORATION
9. PAREXEL INTERNATIONAL CORPORATION
10. VEEVA SYSTEMS INC
